Pressure Injury Prevalence in Intensive Care Versus Acute General Patients: a 5-year Analysis
DOI:
https://doi.org/10.29173/ijcc986Keywords:
pressure injury, Critically Ill Patients, critical care nurseAbstract
Background: ICU patients have multiple risk factors and are vulnerable to pressure injury. Previous studies have shown that pressure injury prevalence and incidence are high in ICU compared to non-ICU samples. However, few studies report mucosal injuries, and many exclude Stage 1 pressure injuries, making benchmarking difficult.
Aim: To analyse state-wide prevalence of hospital-acquired pressure injury (HAPI) in ICU versus non-ICU patients.
Method: Secondary data analysis of five state-wide annual point-prevalence studies between 2015 to 2019. Sample: N = 15678, ICU n = 611.
Results: ICU HAPI prevalence = 9.6% (non-ICU = 2.1%; p < .001); ≥ Stage II ICU HAPI prevalence = 8.6% (non-ICU = 1.2%; p < .001); ICU patients 5 times greater likelihood to have a HAPI than non-ICU patients; ICU patients 7 times greater likelihood to have a ≥ Stage 2 HAPI than non-ICU patients. The proportion of ‘severe’ HAPIs (Stages III-IV and SDTI) in ICU (27.9%) was greater than non-ICU participants (14.4%); p = .004. The largest proportions of ICU HAPIs were on the sacrum/coccyx (20.9%) or heel (16.3%) and there was a significantly greater proportion of hospital-acquired mucosal injuries in ICU patients (1.6% versus 0.1%).
Conclusions: The difference in HAPI prevalence between ICU and non-ICU patients was statistically and clinically significant. The relatively high prevalence of HAPI in ICU indicates that despite heightened awareness of prevention in ICU, they remain a significant clinical problem. Although prevalence was high in this Australian study, it compares favourably with other recent global studies. These results may be used for national and benchmarking.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Paul Fulbrook RN PhD, Dr. Josephine Lovegrove, Professor. Fiona Coyer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.